AU2006327761A1 - Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria - Google Patents

Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria Download PDF

Info

Publication number
AU2006327761A1
AU2006327761A1 AU2006327761A AU2006327761A AU2006327761A1 AU 2006327761 A1 AU2006327761 A1 AU 2006327761A1 AU 2006327761 A AU2006327761 A AU 2006327761A AU 2006327761 A AU2006327761 A AU 2006327761A AU 2006327761 A1 AU2006327761 A1 AU 2006327761A1
Authority
AU
Australia
Prior art keywords
gram positive
bacteria
mice
efd
killed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006327761A
Other languages
English (en)
Inventor
Mohammad Abolhassani
Herve Bercovier
Micheline Lagranderie
Gilles Marchal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Institut Pasteur
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur, Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Institut Pasteur
Publication of AU2006327761A1 publication Critical patent/AU2006327761A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2006327761A 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria Abandoned AU2006327761A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,531,261 2005-12-21
CA002531261A CA2531261A1 (en) 2005-12-21 2005-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
PCT/IB2006/004133 WO2007072230A2 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria

Publications (1)

Publication Number Publication Date
AU2006327761A1 true AU2006327761A1 (en) 2007-06-28

Family

ID=38175409

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006327761A Abandoned AU2006327761A1 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria

Country Status (10)

Country Link
US (1) US20090280146A1 (https=)
EP (1) EP1971352A2 (https=)
JP (1) JP2009520810A (https=)
KR (1) KR20080092384A (https=)
CN (1) CN101384270A (https=)
AU (1) AU2006327761A1 (https=)
CA (2) CA2531261A1 (https=)
IL (1) IL192048A0 (https=)
MX (1) MX2008008157A (https=)
WO (1) WO2007072230A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087898A1 (en) * 2008-02-06 2009-08-12 Institut Pasteur A preparation of mycobacterium bovis BCG killed by extended freeze drying (EFD) for treating rheumatoid arthritis
CA2629057A1 (en) * 2008-04-14 2009-10-14 Institut Pasteur Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria
EP2292260A1 (en) 2009-08-13 2011-03-09 Institut Pasteur Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
NZ702796A (en) * 2010-07-26 2017-03-31 Qu Biologics Inc Immunogenic anti-inflammatory compositions
WO2013004069A1 (zh) * 2011-07-05 2013-01-10 苏州科景生物医药科技有限公司 沙门氏菌鞭毛蛋白衍生物在制备防治炎症性肠病药物中的应用
US9886742B2 (en) 2016-03-17 2018-02-06 Google Llc Electro-optic beam steering for super-resolution/lightfield imagery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR012304A1 (es) * 1997-04-01 2000-10-18 Borody Thomas J Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos.
WO1998047520A1 (en) * 1997-04-24 1998-10-29 Lovelace Respiratory Research Institute Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
GB0106987D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeuitic agent
EP2316466B1 (en) * 2001-12-11 2013-08-21 Institut Pasteur Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
JP2005531289A (ja) * 2002-02-15 2005-10-20 アゲルプ ファーマ ゲーエムベーハー S.aureusエンテロトキシンB由来の免疫調節ペプチド

Also Published As

Publication number Publication date
CN101384270A (zh) 2009-03-11
IL192048A0 (en) 2009-02-11
WO2007072230A3 (en) 2007-11-22
CA2632839A1 (en) 2007-06-28
WO2007072230A2 (en) 2007-06-28
KR20080092384A (ko) 2008-10-15
EP1971352A2 (en) 2008-09-24
MX2008008157A (es) 2008-09-24
JP2009520810A (ja) 2009-05-28
CA2531261A1 (en) 2007-06-21
US20090280146A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
US20220257668A1 (en) Compositions comprising bacterial strains
JP7497433B2 (ja) ラクトバチルス・パラカゼイk56の腸管炎症の緩和における新規な用途
EP3204024B1 (en) Compositions comprising bacterial strains
US20220401499A1 (en) New use of bifidobacterium lactis bl-99 in suppression of intestinal inflammation
US20120082699A1 (en) Method of Producing Rough Strains of Bacteria and Uses Thereof
CN101138573A (zh) 酪酸梭菌、凝结芽孢杆菌制备治疗炎症性肠病药物中的应用
NZ533422A (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
AU2006327761A1 (en) Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
FI120136B (fi) Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi
CA2571886A1 (en) Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
CN114908023B (zh) 一株提高肠道放线菌门相对丰度、抑制促炎症因子表达量的凝结芽孢杆菌
JP2004262773A (ja) 免疫機能改善を目的としたビフィズス菌製剤
JP2024546437A (ja) 疾患を処置するための細菌株
CN116942685B (zh) 酸性羊乳寡糖组合物在制备抗过敏药物或食物中的应用
JP2025518621A (ja) アルツハイマー病および老化の治療および予防のためのラクノスピラ科菌種およびルミノコッカス・ラクタリス菌株
US20040247622A1 (en) Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae
Adilbekova PROBIOTICS AS ADDITIONAL TREATMENT OF RHEUMATOID ARTHRITIS. A REVIEW.
IBRAEVA et al. SCIENCE & HEALTHCARE
Händel et al. P297-Local fuelling of IL-2 determines the tissue localisation of CD4+ Foxp3+ regulatory T cells–proliferating cells signal inflammation and provide IL-2
HK1240831A1 (en) Compositions comprising bacterial strains
HK1240831B (en) Compositions comprising bacterial strains

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application